Tackling KRASG12C-mutated non-small-cell lung cancer: iteration and exploration-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Tackling KRASG12C-mutated non-small-cell lung cancer: iteration and exploration

Published:2024-08 Issue:8 Volume:12 Page:576-577
ISSN:2213-2600
Container-title:The Lancet Respiratory Medicine
language:en
Short-container-title:The Lancet Respiratory Medicine

Author:

Luo Jia,Villaruz Liza C

Publisher

Elsevier BV

Reference9 articles.

1. K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions;Ostrem;Nature,2013

2. Overcoming KRAS-mutant lung cancer;Luo;Am Soc Clin Oncol Educ Book,2022

3. Garsorasib in patients with KRASG12C-mutated non-small-cell lung cancer in China: an open-label, multicentre, single-arm, phase 2 trial;Li;Lancet Respir Med,2024

4. D-1553 (Garsorasib), a potent and selective inhibitor of KRASG12C in patients with NSCLC: phase 1 study results;Li;J Thorac Oncol,2023

5. D-1553: A novel KRASG12C inhibitor with potent and selective cellular and in vivo antitumor activity;Shi;Cancer Sci,2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP